RIGL

RIGEL PHARMACEUTICALS INC

RIGL·766559702·US·Common Stock·Healthcare - Biotechnology-13D/G

RIGL (RIGEL PHARMACEUTICALS INC) is held by 100 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($47.8M), STATE STREET CORP ($30.3M), VANGUARD CAPITAL MANAGEMENT LLC ($20.7M). Net institutional sentiment: Mixed.

100
Holders
(9 Elite)
$327.5M
Total Value
54% (102)
Consensus
55 buying - 47 selling
13F: Insider & Congress:
RIGL

Smart Money Verdict

View all
Held by 100 funds
9 elite

Who's Trading

ActivistARArmistice Capital, LLC6.9%May 15, 2026
ActivistSMSoleus Capital Master Fund, L.P.5.2%May 7, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderMHMOOS WALTER HSell $145KFeb 20, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION6.0%Feb 9, 2026
ActivistARArmistice Capital, LLC4.0%Nov 14, 2025
ActivistMorgan StanleyMorgan Stanley0.7%Oct 7, 2025
ActivistBlackRock, Inc.BlackRock, Inc.7.7%Apr 17, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.8M(+6.3%)$47.8M0.0%
31
Increased
1.1M(+2.7%)$30.3M0.0%
30
New
764,193$20.7M0.0%
39
Decreased
598,378(-2.5%)$16.2M0.0%
0
Increased
544,431(+113.9%)$14.7M0.0%
45
Increased
445,678(+5.0%)$12.1M0.0%
29
Increased
440,626(+3.8%)$11.9M0.0%
29
Decreased
439,101(-34.6%)$11.9M0.0%
0
Increased
405,807(+49.6%)$11M0.0%
38
Increased
379,541(+37.1%)$10.3M0.0%
36
Increased
343,897(+19.3%)$9.3M0.0%
33
Decreased
338,441(-37.2%)$9.2M0.0%
0
Increased
337,427(+30.3%)$9.1M0.0%
35
Decreased
264,410(-38.7%)$7.1M0.0%
0
Increased
216,410(+9.8%)$5.9M0.0%
30
Increased
176,850(+19.0%)$4.8M0.0%
32
Decreased
167,342(-59.5%)$4.5M0.0%
0
New
147,535$4M0.0%
37
Increased
144,131(+23.2%)$3.9M0.0%
32
Increased
151,311(+147.9%)$3.9M0.0%
43

Showing 1-20 of 114

1 / 6
RIGLRIGLRIGEL PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used